Publications by authors named "Julia A Wells"

Mesenchymal stromal cells (MSCs) are multipotent progenitor cells that are of considerable clinical potential in transplantation and anti-inflammatory therapies due to their capacity for tissue repair and immunomodulation. However, MSCs rapidly differentiate once in culture, making their large-scale expansion for use in immunomodulatory therapies challenging. Although the differentiation mechanisms of MSCs have been extensively investigated using materials, little is known about how materials can influence paracrine activities of MSCs.

View Article and Find Full Text PDF
Article Synopsis
  • Bioactive metabolites exhibit diverse biological functions and could serve as valuable tools for future therapeutic research.
  • The study employs nanovibrational stimulation to promote osteogenic differentiation in mesenchymal stem cells without adding external growth factors, offering a clean way to identify metabolites that induce bone formation.
  • The research identifies cholesterol sulfate and fludrocortisone acetate as potent osteogenic metabolites, while highlighting the role of cytoskeletal contractility and cell stiffness in assessing their effectiveness and specificity.
View Article and Find Full Text PDF

The development and maintenance of a functioning vascular system is a critical function for many aspects of tissue growth and regeneration. Vascular endothelial cell in vitro co-culture spheroids are self-organized cell composites that have the capacity to recapitulate the three-dimensional tissue microenvironment. These spheroid testing platforms aim to better understand the mechanisms of functional tissue and how new therapeutic agents can drive these 3D co-culture processes.

View Article and Find Full Text PDF

The current study has investigated the use of decellularised, demineralised bone extracellular matrix (ECM) hydrogel constructs for in vivo tissue mineralisation and bone formation. Stro-1-enriched human bone marrow stromal cells were incorporated together with select growth factors including VEGF, TGF-β3, BMP-2, PTHrP and VitD3, to augment bone formation, and mixed with alginate for structural support. Growth factors were delivered through fast (non-osteogenic factors) and slow (osteogenic factors) release PLGA microparticles.

View Article and Find Full Text PDF